MedTrace Logo

A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

NCT00893880 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2012-10-22

No results posted yet for this study

Summary

A multi-arm trial to evaluate the efficacy and safety of using gaseous nitric oxide to treat moderate to severe tinea pedis.

Conditions

  • Tinea Pedis

Interventions

DRUG

1% gaseous Nitric Oxide blended in Oxygen

1% gaseous nitric oxide blended in oxygen applied for 30-60 minutes over 1-2 consecutive days.

Sponsors & Collaborators

  • Nitric BioTherapeutics, Inc

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2010-01-31
Completion
2010-05-31

Countries

  • Canada
  • Saint Kitts and Nevis

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00893880 on ClinicalTrials.gov